145 related articles for article (PubMed ID: 6791220)
1. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
Kantak KM; Hegstrand LR; Eichelman B
Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
[TBL] [Abstract][Full Text] [Related]
2. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
3. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
Applegate CD
Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
[No Abstract] [Full Text] [Related]
4. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
5. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
[No Abstract] [Full Text] [Related]
6. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
[No Abstract] [Full Text] [Related]
8. Effect of intraventricular injection of 5,7-dihydroxytryptamine on serum gonadotropins and prolactin.
Wuttke W; Hancke JL; Höhn KG; Baumgarten HG
Ann N Y Acad Sci; 1978 Jun; 305():423-36. PubMed ID: 280254
[No Abstract] [Full Text] [Related]
9. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
Hutson PH; Tricklebank MD; Curzon G
Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
[TBL] [Abstract][Full Text] [Related]
10. 6-Hydroxydopa depletion of brain norepinephrine and the function of aggressive behavior.
Thoa NB; Eichelman B; Richardson JS; Jacobowitz D
Science; 1972 Oct; 178(4056):75-7. PubMed ID: 4672239
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
Rodríguez FD; Rodríguez RE
Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
[TBL] [Abstract][Full Text] [Related]
13. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
Saller CF; Stricker EM
Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
[No Abstract] [Full Text] [Related]
15. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypothalamic injections of 5,7-dihydroxytryptamine on elicitation of mouse-killing in rats.
Vergnes M; Kempf E
Behav Brain Res; 1982 Aug; 5(4):387-97. PubMed ID: 6889881
[TBL] [Abstract][Full Text] [Related]
17. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
[TBL] [Abstract][Full Text] [Related]
18. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
Marks PC; O'Brien M; Paxinos G
Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
[No Abstract] [Full Text] [Related]
19. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
Hole K; Johnson GE; Berge OG
Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric action of intraventricular monoamine neurotoxins.
Gershanik OS; Heikkila RE; Duvoisin RC
Brain Res; 1979 Oct; 174(2):345-50. PubMed ID: 487133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
